Finished product development services

Product Description

NEWS: Hot Melt Extruction is the newest technology now available at Midas Pharma.


Midas Pharma Polska Sp. z.o.o. provides a complete range of services for developing and manufacturing finished drug products, and we have expertise and experience to overcome challenging galenical or analytical hurdles. It includes modular development support, customizing drug product development strategies, selecting suitable development partners, project management, assessing, improving and implementing manufacturing processes and analytical methods, onsite supervision of critical development activities, etc.





Midas Pharma Polska Sp. z.o.o.

  • PL
  • 2015
    On CPhI since
Contract Service
Specifications
  • Selling Points
    Experienced Technicians; Quality Service; Reputation
  • Supplied from
    Poland

Midas Pharma Polska Sp. z.o.o.

  • PL
  • 2015
    On CPhI since
Contract Service

More Products from Midas Pharma Polska Sp. z.o.o.

  • Business development & licensing services

    Product Business development & licensing services

    HOT DOSSIERS: Atorvastatin + Ezetimibe tabs, Lenalidomide caps, Levodropropizine syrup

    Midas Pharma Polska Sp. z.o.o. offers company's Own as well as Third Party Dossiers, co-development & contract development

    BD&L services include commercialization strategy, promotion, search strategy and scouting, shortlisting and feasibility checking, negotiation, transaction support, etc.

  • Active Pharmaceutical Ingredients & Intermediates

    Product Active Pharmaceutical Ingredients & Intermediates

    API & IM businesses are belonging to the core areas of Midas Pharma Polska Sp. z o.o. activities. Besides the Third Party products we offer Midas' own APIs like: Warfarin Sodium (CEP), Ketoprofen (CEP in progress), Doxapram HCl, Doxazosin Maleate, Trospium Chloride, Amfepramone  HCl  and IMs like: 5-ALA (5-aminolevulinic acid), R3Q (R-3-Quinuclidinol),  

Recommended products